Antiviral Effects of Propolis Against SARS-COV 2. A Mini Review Article

Authors

  • Rim M Harfouch Department of Microbiology and Biochemistry, Faculty of Pharmacy, Al Sham Private University, Latakia, Syria Author

DOI:

https://doi.org/10.47363/JBBR/2022(4)143

Keywords:

COVID-19, Propolis, Antiviral Activity

Abstract

Propolis, which is produced by honey bees from plant exudates, has long been used in traditional herbal medicine and is widely consumed as an immune system enhancer. The COVID-19 pandemic has renewed interest in propolis products worldwide; fortunately, various aspects of the SARSCoV-2 infection mechanism are potential targets for propolis components. In pre-clinical studies, propolis promoted immunoregulation of proinflammatory cytokines, including reduction in IL-6, IL-1 beta and TNF-α Propolis has also shown promise as an aid in the treatment of various of the comorbidities that are particularly dangerous in COVID-19 patients, including respiratory diseases, hypertension, diabetes, and cancer. In this mini review, we summarize the potential role of COVID-19 treatment and prevention.

Author Biography

  • Rim M Harfouch, Department of Microbiology and Biochemistry, Faculty of Pharmacy, Al Sham Private University, Latakia, Syria

    Rim M Harfouch, Department of Microbiology and Biochemistry, Faculty of Pharmacy, Al Sham Private University, Latakia, Syria

Downloads

Published

2022-01-10

Issue

Vol. 4 No. 1 (2022): Volume 4 Issue 1

Section

Articles